Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes
Authors:
- Heejoo KimHKHeejoo Kim
- Jelena PerovanovicJPJelena Perovanovic
- Arvind ShakyaASArvind Shakya
- Zuolian ShenZSZuolian Shen
- Cody N. GermanCGCody N. German
- Andrea IbarraAIAndrea Ibarra
- Jillian L. JafekJJJillian L. Jafek
- Nai-Pin LinNLNai-Pin Lin
- Brian D. EvavoldBEBrian D. Evavold
- Danny H.-C. ChouDCDanny H.-C. Chou
- Peter E. JensenPJPeter E. Jensen
- Xiao HeXHXiao He
Open Access
- 9 December 2020
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (3)
Abstract
The transcriptional coregulator OCA-B promotes expression of T cell target genes in cases of repeated antigen exposure, a necessary feature of autoimmunity. We hypothesized that T cell–specific OCA-B deletion and pharmacologic OCA-B inhibition would protect mice from autoimmune diabetes. We developed an Ocab conditional allele and backcrossed it onto a diabetes-prone NOD/ShiLtJ strain background. T cell–specific OCA-B loss protected mice from spontaneous disease. Protection was associated with large reductions in islet CD8+ T cell receptor specificities associated with diabetes pathogenesis. CD4+ clones associated with diabetes were present but associated with anergic phenotypes. The protective effect of OCA-B loss was recapitulated using autoantigen-specific NY8.3 mice but diminished in monoclonal models specific to artificial or neoantigens. Rationally designed membrane-penetrating OCA-B peptide inhibitors normalized glucose levels and reduced T cell infiltration and proinflammatory cytokine expression in newly diabetic NOD mice. Together, the results indicate that OCA-B is a potent autoimmune regulator and a promising target for pharmacologic inhibition.Keywords
All Related Versions
Funding Information
- Praespero foundation
- Juvenile Diabetes Research Foundation United States of America (1-INO-2018-647-A-N)
- National Institutes of Health (R01-AI100873)
This publication has 81 references indexed in Scilit:
- Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese PopulationThe American Journal of Human Genetics, 2012
- Arthritogenic Self-Reactive CD4+ T Cells Acquire an FR4hiCD73hi Anergic State in the Presence of Foxp3+ Regulatory T CellsThe Journal of Immunology, 2012
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Oct1 Is a Switchable, Bipotential Stabilizer of Repressed and Inducible Transcriptional StatesJournal of Biological Chemistry, 2011
- An allergy-associated polymorphism in a novel regulatory element enhances IL13 expressionHuman Molecular Genetics, 2009
- Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic MiceDiabetes, 2009
- Mouse models for Type 1 DiabetesDrug Discovery Today: Disease Models, 2009
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008
- Elimination of insulitis and augmentation of islet β cell regeneration via induction of chimerism in overtly diabetic NOD miceProceedings of the National Academy of Sciences, 2007
- JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen ReceptorCell, 2006